RUBRIC CAPITAL MANAGEMENT LP
Q2 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001687509
· CRD 285090
· SEC-registered investment adviser
$10.9B Reported Value Total
RUBRIC CAPITAL MANAGEMENT LP reports 9 total accounts under management (AUM). There are 9 discretionary accounts valued at $9,581,125,895, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
4 funds
· $9.0B gross asset value
Hedge Fund: $8.9B · Private Equity Fund: $90.5M
Source: Form ADV filed 2026-03-30
Reported value
$10.9B
Quarter over quarter
+15.2%
Holdings
86
Top-10 concentration
46.4%
Key People
Form ADV owners & control persons
David Efraim Rosen
LIMITED PARTNER
Brian Wolf Kleinhaus
GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
Margaret Kossakowski
CHIEF FINANCIAL OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | August 14, 2026 |
| Form | 13F-HR |
| Reported value | $10.9B |
| Positions | 86 |
| Change in reported value | +15.5% |
| New positions | 18 |
| Exited positions | 13 |
| Position turnover | 31.3% |
| Top-10 concentration | 46.4% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
86 | $10.9B |
|
Q1 2026 13F
Filed May 15, 2026
|
81 | $9.4B |
|
Q4 2025 13F
Filed Feb 13, 2026
|
75 | $8.4B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
69 | $8.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
62 | $6.6B |
|
Q1 2025 13F
Filed May 14, 2025
|
64 | $5.6B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
66 | $7.8B |
|
Q3 2024 13F
Filed Nov 13, 2024
|
63 | $6.1B |
|
Q2 2024 13F
Filed Aug 13, 2024
|
66 | $3.8B |
|
Q1 2024 13F
Filed May 10, 2024
|
67 | $3.4B |
|
Q4 2023 13F
Filed Feb 13, 2024
|
56 | $4.8B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
59 | $2.7B |
|
Q2 2023 13F
Filed Aug 11, 2023
|
61 | $2.3B |
|
Q1 2023 13F
Filed May 12, 2023
|
70 | $3.9B |
|
Q4 2022 13F
Filed Feb 10, 2023
|
94 | $2.3B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
87 | $2.0B |
|
Q2 2022 13F
Filed Aug 12, 2022
|
88 | $1.9B |
|
Q1 2022 13F
Filed May 13, 2022
|
70 | $2.8B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
68 | $2.1B |
|
Q3 2021 13F
Filed Nov 12, 2021
|
55 | $3.6B |
19 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | TLN TALEN ENERGY CORP | $1.4B | 12.7% |
| 2 | FTAI FTAI AVIATION LTD | $811.6M | 7.45% |
| 3 | VTRS VIATRIS INC | $542.6M | 4.98% |
| 4 | TEVA TEVA PHARMACEUTICAL INDS LTD | $527.7M | 4.84% |
| 5 | GLNG GOLAR LNG LTD | $457.5M | 4.2% |
| 6 | VST VISTRA CORP | $284.7M | 2.61% |
| 7 | TAC TRANSALTA CORP | $279.8M | 2.57% |
| 8 | FLR FLUOR CORP | $262.9M | 2.41% |
| 9 | KNSA KINIKSA PHARMACEUTICALS INTL | $255.8M | 2.35% |
| 10 | BGC BGC GROUP INC | $254.4M | 2.33% |
| 11 | ZM ZOOM COMMUNICATIONS INC | $238.7M | 2.19% |
| 12 | GIL GILDAN ACTIVEWEAR INC | $232.2M | 2.13% |
| 13 | ARQT ARCUTIS BIOTHERAPEUTICS INC | $216.9M | 1.99% |
| 14 | AMZN AMAZON COM INC | $214.5M | 1.97% |
| 15 | ROIV ROIVANT SCIENCES LTD | $212.3M | 1.95% |
| 16 | ZYME ZYMEWORKS INC | $183.0M | 1.68% |
| 17 | AMCRZZZZ AMCOR PLC | $180.4M | 1.66% |
| 18 | CMPR CIMPRESS PLC | $178.0M | 1.63% |
| 19 | AMRX AMNEAL PHARMACEUTICALS INC | $176.0M | 1.61% |
| 20 | NRIX NURIX THERAPEUTICS INC | $175.3M | 1.61% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.